Filtrer efter Last updated date SelectEfterFørFrom - To Dato Slutdato Denne uge Denne måned Seneste uge Seneste måned Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationResearch and developmentMedicine shortagesBiosimilarsSMEAntimicrobial resistanceGovernanceBrexitQuality of medicinesCorporateGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate useCareersMedication errorParallel distributionPRIMEProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety Yes Efterlad dette felt tomt Filter Resultater (3800) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Efterlad dette felt tomt PRAC recommends the same cardiovascular precautions for diclofenac as for selective COX-2 inhibitors 14 juni 2013Press releaseHumanPharmacovigilance PRAC recommends restricting the use of codeine when used for pain relief in children 14 juni 2013Press releaseHumanPaediatricsPharmacovigilance PRAC recommends suspending marketing authorisations for infusion solutions containing hydroxyethyl starch 14 juni 2013Press releaseHumanPharmacovigilance Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 10-13 June 2013 14 juni 2013NewsHumanPharmacovigilance Revised guideline on biosimilars containing biotechnology-derived proteins published for public consultation 10 juni 2013NewsHumanBiosimilarsRegulatory and procedural guidance European Medicines Agency publishes interim fee advice for bluetongue-vaccine manufacturers 7 juni 2013NewsCorporateMedicines Public consultation open on guideline on the acceptability of names for human medicines 7 juni 2013NewsCorporateRegulatory and procedural guidance Comments invited on good-pharmacovigilance-practice module on reporting of adverse reactions 7 juni 2013NewsCorporate European Medicines Agency and EUnetHTA review progress of their cooperation 7 juni 2013Press releaseCorporateMedicines Amendments to the pharmacovigilance legislation: new notification requirements for marketing-authorisation holders 5 juni 2013NewsCorporate 1 … 222 223 224 225 226 Page 226 of 380 227 228 229 230 … 380
PRAC recommends the same cardiovascular precautions for diclofenac as for selective COX-2 inhibitors 14 juni 2013Press releaseHumanPharmacovigilance
PRAC recommends restricting the use of codeine when used for pain relief in children 14 juni 2013Press releaseHumanPaediatricsPharmacovigilance
PRAC recommends suspending marketing authorisations for infusion solutions containing hydroxyethyl starch 14 juni 2013Press releaseHumanPharmacovigilance
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 10-13 June 2013 14 juni 2013NewsHumanPharmacovigilance
Revised guideline on biosimilars containing biotechnology-derived proteins published for public consultation 10 juni 2013NewsHumanBiosimilarsRegulatory and procedural guidance
European Medicines Agency publishes interim fee advice for bluetongue-vaccine manufacturers 7 juni 2013NewsCorporateMedicines
Public consultation open on guideline on the acceptability of names for human medicines 7 juni 2013NewsCorporateRegulatory and procedural guidance
Comments invited on good-pharmacovigilance-practice module on reporting of adverse reactions 7 juni 2013NewsCorporate
European Medicines Agency and EUnetHTA review progress of their cooperation 7 juni 2013Press releaseCorporateMedicines
Amendments to the pharmacovigilance legislation: new notification requirements for marketing-authorisation holders 5 juni 2013NewsCorporate